Ning-Fang Ma
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Ning-Fang Ma has not added Biography.
If you are Ning-Fang Ma and would like to personalize this page please email our Author Liaison for assistance.
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation.
Nature communications Oct, 2017 | Pubmed ID: 29079782
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Stem cells (Dayton, Ohio) Feb, 2018 | Pubmed ID: 29119708
CSTF2-Induced Shortening of the 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder.
Cancer research Oct, 2018 | Pubmed ID: 30143523
A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.
Molecular and cellular biology Feb, 2019 | Pubmed ID: 30455250
CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Cell death & disease Feb, 2019 | Pubmed ID: 30718500
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Hepatology international Jul, 2020 | Pubmed ID: 32304089
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma.
Molecular cancer 01, 2021 | Pubmed ID: 33485358
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Science translational medicine 02, 2021 | Pubmed ID: 33536280
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy Feb, 2021 | Pubmed ID: 33634751
Diversity roles of CHD1L in normal cell function and tumorigenesis.
Biomarker research Mar, 2021 | Pubmed ID: 33663617
CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Cell death & disease Sep, 2021 | Pubmed ID: 34588420
CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3.
Cell death & disease 10, 2021 | Pubmed ID: 34654797
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits.
Experimental hematology & oncology Nov, 2021 | Pubmed ID: 34774101
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
Nature communications 12, 2021 | Pubmed ID: 34880251
Correction to: CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Cell death & disease Mar, 2022 | Pubmed ID: 35236830
Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma.
STAR protocols Dec, 2022 | Pubmed ID: 36595904
Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
Cheng-Yang Zhang*,1,2,
Xiao-Feng Zhang*,3,
Jun Yuan*,1,2,
Yuan-Feng Gong4,
Hui Tang4,
Wan-Yu Guo1,2,
Tong-Yan Li1,2,
Cai-Wen Li1,2,
Yun-Qiang Tang4,
Ning-Fang Ma1,2,
Ming Liu1,2
1, Affiliated Cancer Hospital and Institute of Guangzhou Medical University,
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University,
3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University,
4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유